Stay updated with breaking news from Hans Van. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Needham & Company LLC reaffirmed their buy rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a report published on Tuesday morning, Benzinga reports. They currently have a $31.00 price objective on the stock. Several other research firms have also weighed in on NRIX. Morgan Stanley lifted their price target on Nurix Therapeutics […]
Nurix Therapeutics (NASDAQ:NRIX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a research note issued on Tuesday, Benzinga reports. They presently have a $31.00 price target on the stock. Needham & Company LLC’s price objective would suggest a potential upside of 116.78% from the […]
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) traded down 4.7% on Thursday . The stock traded as low as $14.77 and last traded at $14.92. 472,474 shares changed hands during mid-day trading, a decline of 34% from the average session volume of 713,108 shares. The stock had previously closed at $15.66. Analyst […]
Nurix Therapeutics (NASDAQ:NRIX – Free Report) had its price target lowered by Wells Fargo & Company from $23.00 to $20.00 in a research note published on Friday, Benzinga reports. Wells Fargo & Company currently has an overweight rating on the stock. A number of other research firms also recently weighed in on NRIX. Needham & […]
Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Get Free Report) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have issued a report on […]